Assignee
TLC THERAPEUTICS LLC
US·4 granted patents·1 pending application·14 citations·filing 2017–2024
Top patents by PatentIndex Score
5 records- 0190US10561669B2Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2018·Granted Feb 18, 2020·6 cites·15 claims
- 0288US9993486B1Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2017·Granted Jun 12, 2018·8 cites·13 claims
- 0380US2024342189A1Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 0468US12023340B2Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2021·Granted Jul 2, 2024·0 cites·13 claims
- 0568US10940155B2Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailabilityTLC THERAPEUTICS LLC·Filed 2020·Granted Mar 9, 2021·0 cites·21 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →